etocar metoprolol tartrate 100 mg film-coated tablet blister pack
ipca pharma (australia) pty ltd - metoprolol tartrate, quantity: 100 mg - tablet, film coated - excipient ingredients: hypromellose; croscarmellose sodium; lactose monohydrate; macrogol 400; pregelatinised maize starch; titanium dioxide; magnesium stearate; sodium starch glycollate; microcrystalline cellulose; purified talc; colloidal anhydrous silica - hypertension: as monotherapy or for use in combination with other antihypertensives.,angina pectoris: for long-term prophylaxis. glyceryl trinitrate should be employed if necessary for alleviating acute attacks.,confirmed or suspected myocardial infarction.,prevention of migraine.
etocar metoprolol tartrate 50 mg film-coated tablet blister pack
ipca pharma (australia) pty ltd - metoprolol tartrate, quantity: 50 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; hypromellose; magnesium stearate; iron oxide red; croscarmellose sodium; macrogol 400; microcrystalline cellulose; sodium starch glycollate; titanium dioxide; purified talc; pregelatinised maize starch - hypertension: as monotherapy or for use in combination with other antihypertensives.,angina pectoris: for long-term prophylaxis. glyceryl trinitrate should be employed if necessary for alleviating acute attacks.,confirmed or suspected myocardial infarction.,prevention of migraine.
myotar metoprolol tartrate 100 mg film-coated tablet blister pack
ipca pharma (australia) pty ltd - metoprolol tartrate, quantity: 100 mg - tablet, film coated - excipient ingredients: hypromellose; croscarmellose sodium; lactose monohydrate; macrogol 400; pregelatinised maize starch; titanium dioxide; magnesium stearate; sodium starch glycollate; microcrystalline cellulose; purified talc; colloidal anhydrous silica - hypertension: as monotherapy or for use in combination with other antihypertensives.,angina pectoris: for long-term prophylaxis. glyceryl trinitrate should be employed if necessary for alleviating acute attacks.,confirmed or suspected myocardial infarction.,prevention of migraine.
myotar metoprolol tartrate 50 mg film-coated tablet blister pack
ipca pharma (australia) pty ltd - metoprolol tartrate, quantity: 50 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; hypromellose; magnesium stearate; iron oxide red; croscarmellose sodium; macrogol 400; microcrystalline cellulose; sodium starch glycollate; titanium dioxide; purified talc; pregelatinised maize starch - hypertension: as monotherapy or for use in combination with other antihypertensives.,angina pectoris: for long-term prophylaxis. glyceryl trinitrate should be employed if necessary for alleviating acute attacks.,confirmed or suspected myocardial infarction.,prevention of migraine.
desvenlafaxine sandoz desvenlafaxine 50mg modified release tablets blister
medis pharma pty ltd - desvenlafaxine, quantity: 50 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; hypromellose; citric acid monohydrate; magnesium stearate; povidone; purified talc; alginic acid; titanium dioxide; macrogol 6000; iron oxide red - for the treatment of major depressive disorder, including the preventiton of relapse. not indicated for paediatric use.
desvenlafaxine sandoz desvenlafaxine 100mg modified release tablets blister
medis pharma pty ltd - desvenlafaxine, quantity: 100 mg - tablet, modified release - excipient ingredients: alginic acid; magnesium stearate; povidone; purified talc; hypromellose; citric acid monohydrate; microcrystalline cellulose; titanium dioxide; macrogol 8000; iron oxide red; iron oxide black - for the treatment of major depressive disorder, including the preventiton of relapse. not indicated for paediatric use.
desfax desvenlafaxine 100mg modified release tablets bottle
medis pharma pty ltd - desvenlafaxine, quantity: 100 mg - tablet, modified release - excipient ingredients: alginic acid; citric acid monohydrate; povidone; microcrystalline cellulose; hypromellose; magnesium stearate; purified talc; titanium dioxide; macrogol 8000; iron oxide red; iron oxide black - for the treatment of major depressive disorder, including the preventiton of relapse. not indicated for paediatric use.
desfax desvenlafaxine 50mg modified release tablets bottle
medis pharma pty ltd - desvenlafaxine, quantity: 50 mg - tablet, modified release - excipient ingredients: citric acid monohydrate; microcrystalline cellulose; alginic acid; povidone; hypromellose; magnesium stearate; purified talc; titanium dioxide; macrogol 6000; iron oxide red - for the treatment of major depressive disorder, including the preventiton of relapse. not indicated for paediatric use.
desven desvenlafaxine 100mg modified release tablets blister
medis pharma pty ltd - desvenlafaxine, quantity: 100 mg - tablet, modified release - excipient ingredients: magnesium stearate; microcrystalline cellulose; alginic acid; purified talc; citric acid monohydrate; povidone; hypromellose; titanium dioxide; macrogol 8000; iron oxide red; iron oxide black - for the treatment of major depressive disorder, including the preventiton of relapse. not indicated for paediatric use.
desfax desvenlafaxine 50mg modified release tablets blister
medis pharma pty ltd - desvenlafaxine, quantity: 50 mg - tablet, modified release - excipient ingredients: citric acid monohydrate; povidone; alginic acid; microcrystalline cellulose; magnesium stearate; purified talc; hypromellose; titanium dioxide; macrogol 6000; iron oxide red - for the treatment of major depressive disorder, including the preventiton of relapse. not indicated for paediatric use.